STREP-A RESPI-STRIP CORIS BIOCONCEPT
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PHARMACUR, S.A. DE C.V.·Registered October 11, 2018PRUEBA RÁPIDA DE DIAGNÓSTICO IN VITRO PARA DETECCIÓN DE INFECCIÓN HUMANA POR ESTREPTOCOCO GRUPO A EN MUESTRAS DE HISOPO FARÍNGEO
RAPID IN VITRO DIAGNOSTIC TEST FOR DETECTION OF HUMAN GROUP A STREPTOCOCCAL INFECTION IN PHARYNGEAL SWAB SAMPLES
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA DETECCIÓN DE ESTREPTOCOCOS
- Trade Name (English)
- STREPTOCOCCAL TEST
- Analysis ID
- 2338R2018 SSA
- Registration Date
- October 11, 2018
- Name (Spanish)
- PHARMACUR, S.A. DE C.V.
- Name (English)
- PHARMACUR, S.A. DE C.V.
Access comprehensive regulatory information for STREP-A RESPI-STRIP CORIS BIOCONCEPT (STREP-A RESPI-STRIP CORIS BIOCONCEPT) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2338R2018 SSA and manufactured by PHARMACUR, S.A. DE C.V.. The device was registered on October 11, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.